GAINN Q1 2026 Earnings EPS Misses Estimates Amid Stable Note Pricing Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development DXC Q1 2026 Earnings EPS Surpasses Estimates as Cost Actions Drive Profitability CPIX Q1 2026 Earnings Narrowing Losses and Strategic Progress Amidst Revenue Challenges BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rally on Strong Performance TJX Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction